Login to your account

Username *
Password *
Remember Me

Long Covid: Study shows persistence of symptoms in a third of ambulatory patients 30 to 45 days after diagnosis

COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings – Annals of Internal Medicine Commentary: COVID-19: persistent symptoms in one third of cases – Université de Genève   Commentary on Twitter Study of 669 people who had #COVID19 during the first wave in Switzerland. Of 510 who were followed up for 30-45 days, 32% still […]

The post Long Covid: Study shows persistence of symptoms in a third of ambulatory patients 30 to 45 days after diagnosis appeared first on Links Medicus.

Healthcare workers 7 times as likely to have severe COVID-19 as other workers

Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants – Occupational & Environmental Medicine Commentary: Healthcare workers 7 times as likely to have severe COVID-19 as other workers – BMJ   Commentary on Twitter Of essential workers, who has the highest risk of severe #COVID19?Healthcare workforce >7X. Non-white >8X.https://t.co/ZBUJYccXlT […]

The post Healthcare workers 7 times as likely to have severe COVID-19 as other workers appeared first on Links Medicus.

Just published: Pfizer vaccine confers 95% protection against Covid-19

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine – New England Journal of Medicine Editorial: SARS-CoV-2 Vaccination — An Ounce (Actually, Much Less) of Prevention Commentary: Pfizer vaccine results published in peer-reviewed journal – MedicalXpress Related: FDA advisory panel endorses Pfizer/BioNTech Covid-19 vaccine – STAT   Commentary on Twitter (Thread – Click for more) […]

The post Just published: Pfizer vaccine confers 95% protection against Covid-19 appeared first on Links Medicus.

“COVID-19: when are you most infectious?” This commentary from the authors of a recent meta-analysis highlights the findings that infectiousness peaks within the first 5 days of symptom onset

COVID-19: when are you most infectious? – The Conversation Original study and commentaries: Meta-analysis: SARSCoV2 most contagious within the first 5 days of symptom onset  

The post “COVID-19: when are you most infectious?” This commentary from the authors of a recent meta-analysis highlights the findings that infectiousness peaks within the first 5 days of symptom onset appeared first on Links Medicus.

UK to refine allergy warning on Pfizer vaccine sparked by two adverse reactions

UK to refine allergy warning on Pfizer vaccine sparked by two adverse reactions – Reuters See also: UK probes whether COVID-19 vaccine caused allergic reactions – Associated Press AND NHS told not to give Covid vaccine to those with history of allergic reactions – The Guardian  

The post UK to refine allergy warning on Pfizer vaccine sparked by two adverse reactions appeared first on Links Medicus.

Systematic review: Men with COVID-19 have almost three times the risk of requiring ICU admission and a higher risk of death

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission – Nature Medicine Commentary: Men face ‘almost three times the odds’ of ICU admission for Covid-19, study says – CNN AND Men with COVID-19 three times more likely to need intensive care: study – MedicalXpress   Commentary on Twitter […]

The post Systematic review: Men with COVID-19 have almost three times the risk of requiring ICU admission and a higher risk of death appeared first on Links Medicus.

Another randomized trial shows hydroxychloroquine is not effective as postexposure prophylaxis to prevent Covid-19

Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial – Annals of Internal Medicine Summary for patients: Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection  

The post Another randomized trial shows hydroxychloroquine is not effective as postexposure prophylaxis to prevent Covid-19 appeared first on Links Medicus.

CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk

CDC Releases New Ventilation Guidelines For Indoor Environments To Reduce Covid-19 Risk – Forbes CDC Guideline: Ventilation Related podcast: Air Handling Standards for Increasing the Safety of Indoor Spaces During the COVID-19 Pandemic – JAMA  

The post CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk appeared first on Links Medicus.

Just published: AstraZeneca-Oxford Covid-19 vaccine shows moderate efficacy, but questions remain about the most effective dosing regimen

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK – The Lancet Commentaries: Oxford COVID vaccine paper highlights lingering unknowns about results – Nature AND Detailed data on AstraZeneca-Oxford Covid-19 vaccine show it has moderate efficacy – STAT […]

The post Just published: AstraZeneca-Oxford Covid-19 vaccine shows moderate efficacy, but questions remain about the most effective dosing regimen appeared first on Links Medicus.

Opinion: “Get ready for vaccine false side effects”. When millions of people are vaccinated, naturally occurring health problems could be wrongly attributed to vaccines